Article Details
Retrieved on: 2021-09-09 19:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Germany-based TIB Molbiol Group develops ultra-rapid assays aimed at infectious diseases. The acquisition will enable Roche to expand its own ...
Article found on: www.pharmalive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here